908 DEVICES INC. (MASS) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $38.00K; Additional Paid in CapitalUSD $374.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-730.00K; Retained Earnings (Accumulated Deficit)USD $-247.16M.
- 2026-03-31: Common Stock, Value, IssuedUSD $37.00K; Additional Paid in CapitalUSD $369.40M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.00K; Retained Earnings (Accumulated Deficit)USD $-235.27M.
- 2025-12-31: Common Stock, Value, IssuedUSD $36.00K; Additional Paid in CapitalUSD $366.93M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $54.00K; Retained Earnings (Accumulated Deficit)USD $-223.32M.
- 2025-09-30: Common Stock, Value, IssuedUSD $36.00K; Additional Paid in CapitalUSD $363.71M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $43.00K; Retained Earnings (Accumulated Deficit)USD $-227.49M.
908 DEVICES INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Common Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $38.00K | $374.62M | $-730.00K | $-247.16M | $126.77M | 3 month · $2.31M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $37.00K | $369.40M | $2.00K | $-235.27M | $134.17M | 3 month · $2.40M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $36.00K | $366.93M | $54.00K | $-223.32M | $143.70M | 12 month · $9.85M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $36.00K | $363.71M | $43.00K | $-227.49M | $136.30M | 3 month · $2.38M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $36.00K | $361.31M | $-16.00K | $-212.51M | $148.82M | 3 month · $2.34M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $36.00K | $358.59M | $-2.00K | $-199.20M | $159.42M | 3 month · $2.37M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $35.00K | $356.22M | $1.15M | $-242.81M | $114.59M | 12 month · $11.76M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $35.00K | $352.80M | $1.57M | $-223.36M | $131.04M | 3 month · $3.20M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $35.00K | $349.53M | $858.00K | $-194.06M | $156.36M | 3 month · $3.10M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $33.00K | $337.40M | $980.00K | $-181.52M | $156.89M | 3 month · $2.64M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $33.00K | $334.69M | $1.36M | $-170.60M | $165.49M | 12 month · $9.79M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $32.00K | $332.08M | $988.00K | $-163.17M | $169.93M | 3 month · $2.70M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $32.00K | $329.36M | $1.14M | $-156.08M | $174.46M | 3 month · $2.58M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $32.00K | $326.22M | $1.09M | $-146.73M | $180.61M | 3 month · $2.17M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $32.00K | $323.97M | $798.00K | $-134.20M | $190.60M | 12 month · $7.21M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $32.00K | $321.49M | $-613.00K | $-124.41M | $196.50M | 3 month · $2.02M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $32.00K | $319.23M | (m) | $-118.15M | $201.12M | 3 month · $1.89M | (m) | (m) | (m) | (m) |
| 2022-03-31 | $31.00K | $316.82M | (m) | $-110.05M | $206.80M | 3 month · $1.29M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $31.00K | $315.21M | (m) | $-100.64M | $214.60M | 12 month · $2.50M | (m) | (m) | 12 month · $376.00K | (m) |
| 2021-09-30 | $28.00K | $219.92M | (m) | $-97.17M | $122.78M | 3 month · $811.00K | (m) | (m) | (m) | (m) |
| 2021-06-30 | $28.00K | $218.63M | (m) | $-91.99M | $126.67M | 3 month · $481.00K | (m) | (m) | (m) | (m) |
| 2021-03-31 | $27.00K | $217.85M | (m) | $-84.56M | $133.31M | 3 month · $339.00K | $0.00 | $27.30M | (m) | (m) |
| 2020-12-31 | $27.00K | $217.48M | (m) | $-78.47M | $139.04M | 12 month · $525.00K | $0.00 | $27.27M | 12 month · $2.47M | 12 month · $90.00K |
| 2020-09-30 | (m) | (m) | (m) | (m) | $-65.61M | 3 month · $83.00K | (m) | (m) | (m) | 3 month · $21.00K |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-63.95M | 3 month · $69.00K | (m) | (m) | (m) | 3 month · $23.00K |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-66.09M | 3 month · $66.00K | (m) | (m) | (m) | 3 month · $30.00K |
| 2019-12-31 | (m) | (m) | (m) | (m) | $-63.17M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |